Neurocrine Biosciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,919 53,140 77,413 33,501
Cost of Revenue - - - -
Gross Profit 2,919 53,140 77,413 33,501
Operating Expenses
Research and Development 39,248 37,163 30,951 31,151
Sales, General and Admin. 13,349 14,529 12,540 16,072
Non-Recurring Items - - - -
Other - - - -
Operating Income (49,678) 1,448 33,922 (13,722)
Income From Continuing Operations
Add'l Income/Expense Items 3,588 3,577 3,649 5,754
Earnings Before Interest and Tax (46,090) 5,025 37,571 (7,968)
Interest Expense - - - -
Earnings Before Tax (46,090) 5,025 37,571 (7,968)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (46,090) 5,025 37,571 (7,968)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (46,090) 5,025 37,571 (7,968)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (46,090) 5,025 37,571 (7,968)